Cell Therapy Human Raw Materials Market Size Is Expected To Reach USD 11.44 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiuogZ0gYRtQSc_IuNsFbtMU0ZPpmEjnn2XLxc_73oRMtvk4S5kbMuSyjJyJ_y7YLdn6T94u5zmignSnwW4myDbGm-uM6UwOqpF_r2PiL-iYJCmrWc64VXyTVY0KabbStbr4-bPzOmj3niLcbTeBup5pd0REuNHjXpgr4rP_pQJTiYC5qeJUxptKTUab0aL/s320/Cell%20Therapy%20Human%20Raw%20Materials%20Market.png)
San Francisco, 1 April 2024: The Report Cnaverell Therapy Human Raw Materials Market Size, Share & Trends Analysis Report, By Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements), By End Use, By Region, And Segment Forecasts, 2024 - 2030 The global cell therapy human raw materials market size is expected to reach USD 11.44 billion by 2030 and is projected to expand at a CAGR of 22.32% from 2024 to 2030 according to a new report by Grand View Research, Inc. This is attributed to increasing investment in cell therapy research & development, growing number of clinical trials and rising adoption of regenerative & personalized medicines. The field of cell therapy R&D has seen substantial growth in investments in recent years, fueling the development of next-generation treatments like CAR T-cell therapies. This surge in activity has advanced the understanding of cell biology, immunology, & gene editing, leading to the identification of novel ther